Stay updated on SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial
Sign up to get notified when there's something new on the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page.

Latest updates to the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page
- Check4 days agoChange DetectedThe site revision label was updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedAdded site revision tag: v3.4.2. The government funding lapse notice was removed, and no study-specific content was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check40 days agoChange DetectedAdded a government funding notice about potential delays and directs users to opm.gov for status updates, and updated the site revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check47 days agoChange DetectedThe page now includes a glossary toggle. Footer text was updated to show 'Last Update Submitted that Met QC Criteria' with capitalization changes, and it adds 'No FEAR Act Data' and 'Revision: v3.4.0' while the previous 'No FEAR Act data' wording is removed.SummaryDifference0.2%

- Check61 days agoChange DetectedMinor page revision: Revision v3.3.4 was added and v3.3.3 removed. No changes to study details, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check82 days agoChange DetectedFooter updates include adding Revision: v3.3.3 and removing Revision: v3.3.2, as well as deleting the HHS Vulnerability Disclosure link. The study details page content remains unchanged.SummaryDifference0.1%

Stay in the know with updates to SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy Patients 4+ Brain Metastases Melanoma Clinical Trial page.